The Ozempic® injection is supplied as a clear, colorless solution that contains 2 mg of semaglutide in a 1.5 mL (1.34 mg/mL), pre-filled, disposable, single-patient-use pen in the following packaging configurations:
Ozempic® is available in multi-use pens with needles included1
Red-label pen only delivers the starting dose of 0.25 mg and a maintenance dose of 0.5 mg
The 0.25 mg dose is intended for treatment initiation and is not effective for glycemic control.
Blue-label pen only delivers the maximum maintenance dose of 1 mg
Each multi-use pen contains 2 mg of Ozempic® and comes with the thinnest needle available on a once-weekly GLP-1 RA
Understanding the difference between the 2 Ozempic® pens
See how the 2 pens work and how to help patients identify the correct packaging and pen for their prescribed dose.